Dr. Agarwal's Health Care · NSE: AGARWALEYE · BSE: 544350
Q1 FY26 results · Apr–Jun 2025
Dr. Agarwal's Health Care reported revenue from operations of ₹487.42 crore and net profit of ₹38.06 crore for Q1 FY26 (Apr–Jun 2025), on a consolidated basis.
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 487.42 | — | — | 460.22 | +5.9% |
| Other income | 13.39 | — | — | 15.43 | −13.2% |
| Total income | 500.81 | — | — | 475.65 | +5.3% |
| Profit before tax | 53.60 | — | — | 58.52 | −8.4% |
| Net profit for the period | 38.06 | — | — | 42.55 | −10.6% |
| Attributable to shareholders of the company | 30.05 | — | — | 32.57 | −7.7% |
| EPS, basic (₹) | 0.95 | — | — | 1.04 | −8.7% |
| Net margin (%) | 7.8 | — | 9.2 |
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 301.72 | — | — | 281.02 | +7.4% |
| Other income | 13.03 | — | — | 26.93 | −51.6% |
| Total income | 314.75 | — | — | 307.95 | +2.2% |
| Profit before tax | 15.59 | — | — | 34.05 | −54.2% |
| Net profit for the period | 10.11 | — | — | 26.51 | −61.9% |
| EPS, basic (₹) | 0.32 | — | — | 0.85 | −62.4% |
| Net margin (%) | 3.4 | — | 9.4 |
Consolidated
- Filed with BSE
- 12 Aug 2025, 20:44 IST
- Board meeting
- 12 Aug 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 12 Aug 2025, 20:44 IST
- Board meeting
- 12 Aug 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE